FDA lifts partial hold on OncoMed's ipafricept

For the second time in the past week, the FDA has lifted a partial hold on the Phase I studies of one of OncoMed Pharmaceuticals' drugs, this time ipafricept (FZD8-Fc, OMP-54F28), clearing the way for it to move forward.